🇪🇺 Methamphetamine Addiction Treatment · Greece

Methamphetamine use places a severe strain on both physical and mental health, and finding the right support is critical. At European Addiction Centers (EAC), we connect individuals across Greece with accredited, private clinics that specialise in methamphetamine addiction treatment. In 2022, the EMCDDA reported that over 1.7 million adults in the European Union had used amphetamines in the past year, highlighting the widespread nature of this challenge. We offer a pathway to structured, evidence-based care tailored to your needs. Learn more about our approach to Methamphetamine Addiction Treatment here.

Methamphetamine use in Greece, while lower than in some northern European countries, presents a growing public health concern. According to the Greek National Documentation and Monitoring Centre for Drugs (EKTEKN), methamphetamine seizures have increased significantly in recent years, particularly in port cities like Piraeus and Thessaloniki, which serve as transit hubs for the Balkan drug route. The EMCDDA’s European Drug Report notes that amphetamine-related hospital emergencies have risen across Europe, including Greece, where poly-drug use (combining methamphetamine with alcohol or benzodiazepines) is common.

Legally, Greece maintains a strict prohibitionist stance: possession, use, and trafficking of methamphetamine are criminal offences, though personal use cases may be referred to addiction treatment programmes by prosecutors rather than prison. Cultural stigma around drug use remains a barrier to seeking help, particularly in rural areas of the Peloponnese and Crete, where family reputation is highly valued. However, private treatment options are growing in Athens and Thessaloniki, offering confidential care away from local judgment. EAC partners with accredited rehab centres in Greece to provide discreet, medically supervised support.

Methamphetamine addiction manifests through distinct physical and psychological signs. Physically, users may experience rapid weight loss, dental decay (“meth mouth”), skin sores from scratching, and dilated pupils. Behaviourally, symptoms include increased agitation, paranoia, insomnia, and repetitive motor activities. The psychological impact is profound: chronic use alters dopamine pathways, leading to anxiety, depression, and psychosis—often requiring dual diagnosis treatment for co-occurring mental health conditions.

For families and workplaces, the consequences are equally severe. Financial instability, relationship breakdowns, and reduced productivity are common. Early recognition of these signs is vital, as methamphetamine use can escalate quickly. In Greece, where family support networks are strong, involving loved ones in the treatment process can improve outcomes.

EAC connects patients with a range of private treatment options for methamphetamine addiction across Greece. These include residential inpatient programmes (typically 30 to 90 days), day programmes, intensive outpatient services, and medically supervised detoxification. Evidence-based therapies are central to all programmes: Cognitive Behavioural Therapy (CBT) helps restructure thought patterns, while Dialectical Behaviour Therapy (DBT) supports emotional regulation. Contingency Management, a reward-based approach, has shown strong results for stimulant use disorders.

Many partner clinics offer 12-step facilitation and trauma-informed therapies like EMDR for underlying issues. All clinics operate with multilingual staff—Greek, English, German, and French—and adhere to strict GDPR-compliant confidentiality. Whether you are in Athens, Thessaloniki, or a remote island, EAC can place you in a clinic that meets your clinical needs. Treatment is private, which means no waiting lists, and all programmes are accredited by Greek health authorities.

EAC connects patients with a range of private treatment options for methamphetamine addiction across Greece. These include residential inpatient programmes (typically 30 to 90 days), day programmes, intensive outpatient services, and medically supervised detoxification. Evidence-based therapies are central to all programmes: Cognitive Behavioural Therapy (CBT) helps restructure thought patterns, while Dialectical Behaviour Therapy (DBT) supports emotional regulation. Contingency Management, a reward-based approach, has shown strong results for stimulant use disorders.

Many partner clinics offer 12-step facilitation and trauma-informed therapies like EMDR for underlying issues. All clinics operate with multilingual staff—Greek, English, German, and French—and adhere to strict GDPR-compliant confidentiality. Whether you are in Athens, Thessaloniki, or a remote island, EAC can place you in a clinic that meets your clinical needs. Treatment is private, which means no waiting lists, and all programmes are accredited by Greek health authorities.

Your care follows a clear, structured pathway:

This process ensures continuity of care from first contact to long-term recovery.

1. 1. Free confidential assessment: Contact us by phone or online form. A specialist will respond the same day to understand your situation.
2. 2. Personalised treatment plan: A clinical team reviews your history, dual diagnosis needs, and preferences to design a tailored programme.
3. 3. Placement and admission: We match you with an accredited partner clinic in Greece, handling all logistics and paperwork.
4. 4. Treatment programme: For methamphetamine addiction, the typical residential stay is 28 to 90 days, combining individual therapy, group work, and medical monitoring.
5. 5. Aftercare and relapse prevention: Before discharge, you receive a comprehensive plan including ongoing therapy, support groups, and check-ins with EAC’s aftercare coordinators.